Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC5089 Terutroban Sodium Selective Thromboxane_receptor>thromboxane receptor antagonist
DCC5090 Tet3.0 Mutually Orthogonal Bioorthogonal Amino Acid, Enabling Efficient Protein Dual-Labeling in Cells
DCC5091 Tetrabenazine Reversible inhibitor of vesicular monoamine transporter 2, showing anti-chorea effect and decreasing uptake of monamines into synaptic vesicles, as well as depletion of monoamine storage
DCC5092 Tetrabromobisphenol A Activator of the hepatic interferon pathway in rats
DCC5093 Tetracenomycin X Potent inhibitor of protein synthesis, inhibiting translation by binding within the ribosomal exit tunnel
DCC5094 Tetrazanbigen Inducer of S phase arrest and apoptosis in hepatocellular carcinoma QGY-7701
DCC5095 Texaline Antitubercular agent
DCC5096 Texasin Potent and selective human leukocyte 5-lipoxygenase (5-LOX) inhibitor
DCC5097 Tezosentan Novel endothelin (ET) receptor antagonist
DCC5098 Tfah-10n Novel multipotent anti-Alzheimer agent, selectively inhibiting human butyrylcholinesterase (BChE), having strong antioxidant activity and good β-amyloid (Aβ) anti-aggregation properties
DCC5099 Tfgf-18 Novel GSK-3β inhibitor, showing anti-neuroinflammatory effects in lipopolysaccharide (LPS) activation of spontaneously immortalized SIM-A9 microglial cells and of mouse cortical microglia, inhibiting LPS-induced production of nitric oxide and the proinfla
DCC5100 Tfmo-1 Novel cell-active, selective class IIa HDAC inhibitor
DCC5101 Tfmo-12 CNS-penetrant selective class IIa histone deacetylase (HDAC) inhibitor, exploiting the >100-fold selectivity over class I/IIb HDACs
DCC5102 Tfr4oht Cyclized tamoxifen analog, selective ER modulator (SERM)
DCC5103 Tg-0054 Novel and Potent Stem Cell Mobilizer; Inhibitor of SDF-1α/CXCR4 binding
DCC5104 Tg-0205221 Novel potent SARS coronavirus (CoV) 3CL protease inhibitor (Ki = 53 nM)
DCC5105 Tg100948 Novel dual VEGFR/Src kinase inhibitor
DCC5106 Tg101114 Novel inhibitor of T315I mutant enzyme, exhibiting reasonable in vivo efficacy in a xenograft mouse model harboring T315I
DCC5107 Tg11-77 Hydrochloride Novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist
DCC5108 Tg-2112x Novel inhibitor of mitochondrial calcium uptake (#333333; font-family: "Open Sans", HelveticaNeue, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 15px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight:
DCC5109 Tg2-in-3h Highly selective, potent, cell-permeable fluorescent irreversible tissue transglutaminase (TG2) inhibitor
DCC5110 Tg3-95-1 EP2 allosteric potentiator
DCC5111 Tg4-166 Potent and selective nociceptin opioid receptor (NOP) agonist
DCC5112 tg4-290-1 Potent and selective nociceptin opioid receptor (NOP) agonist
DCC5113 tg4-292-1 Potent and selective nociceptin opioid receptor (NOP) agonist
DCC5114 Tg4-294-2 Potent and Selective Antagonist for Human EP2 Receptors
DCC5115 Tgp-200c Novel potent and structure-specific inhibitor of pre-miR-200c, reversing a type 2 diabetes phenotype
DCC5116 Tgr5 Agonist 11d-na Novel potent TGR5 agonist, displayind a significant glucose-lowering effect and stimulated GLP-1 and insulin secretion in TGR5H88Y mice but not in wild-type animals
DCC5117 Tgr5-agonist-17 Novel Potent Agonist of TGR5 Receptor
DCC5118 Tgx-115 Cell-permeable, potent, and selective inhibitor of PI 3-K isoforms p110ß/p110d

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X